TenderlineUK
Procurement Intelligence
Official OCDS

BIOGEN IDEC LIMITED — UK Government Contract Awards

Maidenhead, UKJ11, GB
Procurements won
23
Awards
34
Distinct buyers
10
Awarded GBP value
£0
Published organisation identifiers
GB-COH:01497267GB-FTS-104221GB-FTS-122620GB-FTS-141106GB-FTS-151674GB-FTS-23243GB-FTS-23572GB-FTS-5316GB-FTS-55612GB-FTS-58901GB-FTS-75358GB-PPON:PTGT-3385-PBMQ
Recent awards
Award / procedureBuyerAwardedAward value
Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London & South of EnglandNHS England15 Jun 2026, 00:00 BST£35,312,548
Lot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & EastNHS England15 Jun 2026, 00:00 BST£665,389,588
Lot 2 -CM/PHR/25/5731/02 – NHS Branded Medicines for Ustekinumab for North of England and Midlands & EastNHS England1 Jun 2026, 00:00 BST£18,903,212
Lot 1 - CM/PHR/25/5731/01 – NHS Branded Medicines Tranche B for London & South of England.NHS England1 Jun 2026, 00:00 BST£813,863,584
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS EnglandNot publishedNot published
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS EnglandNot publishedNot published
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026NHS EnglandNot publishedNot published
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation, Procurement and Logistics ServiceNot publishedNot published
Ranibizumab vials and Pre-filled SyringesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not publishedNot published
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025NHS EnglandNot publishedNot published